SARASOTA, FL - Silo Pharma , Inc. (NASDAQ:SILO), a $6.91 million market cap biopharmaceutical company currently trading at $1.54 per share, has announced promising preliminary results from a study on ...
Hims & Hers is under scrutiny for promoting compounded weight-loss drugs in a Super Bowl ad without clear FDA approval or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback